Role of circulating vascular endothelial growth factor and hepatocyte growth factor in patients with coronary artery disease

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Heart and Vessels

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/PL00007263PMID 11289497
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatocyte growth factor (HGF): A new biochemical marker for acute myocardial infarction

  2007cited by this paper
• Elevation of vascular endothelial growth factor-A serum levels following acute myocardial infarction. Evidence for its origin and functional significance.

  2000cited by this paper
• Hepatocyte growth factor (HGF) as a potential index of severity of hypertension.

  1999cited by this paper
• Prognostic value of serum hepatocyte growth factor in patients with acute coronary syndromes.

  1999cited by this paper
• Elevated circulating levels of basic fibroblast growth factor and vascular endothelial growth factor in patients with acute myocardial infarction.

  1999cited by this paper
• Hepatocyte growth factor is a major mediator in heparin-induced angiogenesis.

  1999cited by this paper
• Low-dose basic fibroblast growth factor and vascular endothelial growth factor for angiogenesis in canine acute hindlimb insufficiency.

  1998cited by this paper
• Circulating hepatocyte growth factor as an early marker of arterial thrombus formation.

  1998cited by this paper
• Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis.

  1998cited by this paper
• [Vascular endothelium-related factors and atherosclerosis/arteriosclerosis: serum hepatocyte growth factor as a possible indicator of vascular lesions].

  1998cited by this paper
• Serum levels of vascular endothelial growth factor in patients with acute myocardial infarction undergoing reperfusion therapy.

  1997cited by this paper
• Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor

  1997cited by this paper
• Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries.

  1997cited by this paper
• Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model.

  1997cited by this paper
• Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium.

  1996cited by this paper
• Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction.

  1996cited by this paper
• VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis.

  1996cited by this paper
• Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells.

  1996cited by this paper
• Hepatocyte growth factor is the most potent endogenous stimulant of rabbit gastric epithelial cell proliferation and migration in primary culture.

  1995cited by this paper
• Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo.

  1995cited by this paper
• Hypoxia Induces Vascular Endothelial Growth Factor in Cultured Human Endothelial Cells (*)

  1995cited by this paper
• Regulation of vascular endothelial growth factor in cardiac myocytes.

  1995cited by this paper
• Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only.

  1994cited by this paper
• Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs.

  1994cited by this paper
• Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart.

  1994cited by this paper
• Indirect Angiogenic Cytokines Upregulate VEGF and bFGF Gene Expression in Vascular Smooth Muscle Cells, Whereas Hypoxia Upregulates VEGF Expression Only

  1994cited by this paper
• Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis.

  1994cited by this paper
• Activation of the zymogen of hepatocyte growth factor activator by thrombin.

  1993cited by this paper
• Scatter factor induces blood vessel formation in vivo.

  1993cited by this paper
• Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart.

  1993cited by this paper
• Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII.

  1993cited by this paper
• Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

  1992cited by this paper
• Molecular and biological properties of the vascular endothelial growth factor family of proteins.

  1992cited by this paper
• Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

  1992cited by this paper
• Hepatocyte growth factor--scatter factor: mitogen, motogen, and met.

  1991cited by this paper
• A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor.

  1991cited by this paper
• Native and recombinant human hepatocyte growth factors are highly potent promoters of DNA synthesis in both human and rat hepatocytes.

  1991cited by this paper
• Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor.

  1991cited by this paper
• Molecular cloning and expression of human hepatocyte growth factor

  1989cited by this paper
• Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.

  1989cited by this paper
• Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts.

  1989cited by this paper
• Scatter factor is a fibroblast-derived modulator of epithelial cell mobility

  1987cited by this paper
• Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects.

  1985cited by this paper
• Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats.

  1984cited by this paper
• Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

  1983cited by this paper

• The role of the senescence-associated secretory phenotype in cardiovascular disease among the elderly.

  2025cites this paper
• Correlation between circulating vascular endothelial growth factor levels and coronary artery disease and its influence on the establishment of coronary collateral circulation: a systematic review and meta-analysis

  2021cites this paper
• Measurement of Hepatocyte Growth Factor, Interleukin 6 and Tumor necrosis factor α in Acute Myocardial Infarction

  2019cites this paper
• Angiogenesis-Based Strategy by Hepatocyte Growth Factor for the Treatment of Ischemic Organ Diseases: From Biology to Clinical Trials

  2017cites this paper
• Intramyocardial delivery of VEGF165 via a novel biodegradable hydrogel induces angiogenesis and improves cardiac function after rat myocardial infarction

  2016cites this paper
• Stable phase post-MI patients have elevated VEGF levels correlated with inflammation markers, but not with atherosclerotic burden

  2014cites this paper
• In Vitro Endothelial Cell Proliferation Assay Reveals Distinct Levels of Proangiogenic Cytokines Characterizing Sera of Healthy Subjects and of Patients with Heart Failure

  2014cites this paper
• EL TRASPLANTE INTRACORONARIO DE CÉLULAS MONONUCLEARES DE MÉDULA ÓSEA SE ASOCIA A MEJORÍAA LA FUNCIÓN VENTRICULAR IZQUIERDA, EN PACIENTES CON CARDIOPATÍAA DILATADA DE DIFERENTE ETIOLOGÍA: PROYECTO INNOVA CHILE N° 205-4350

  2013cites this paper
• Physiological Roles and Therapeutic Implications of Hepatocyte Growth Factor for Angiogenesis

  2013cites this paper
• RETRACTED ARTICLE: A novel method of augmenting gene expression and angiogenesis in the normal and ischemic canine myocardium

  2012cites this paper
• Granulocyte-colony stimulating factor therapy to induce neovascularization in ischemic heart disease.

  2012cites this paper
• Retraction Note: A novel method of augmenting gene expression and angiogenesis in the normal and ischemic canine myocardium

  2012cites this paper
• Periodontitis and coronary artery disease : Studies on the association between periodontitis and coronary artery disease

  2012cites this paper
• Interpretation of elevated serum VEGF concentrations in patients with myocardial infarction.

  2011cites this paper
• Circulating CD34+ progenitor cells and growth factors in patients treated with PCI for acute myocardial infarction or stable angina pectoris

  2011cites this paper
• Clinical Trials in Renal Regenerative Medicine

  2011cites this paper
• Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function.

  2009cites this paper
• CONTROLLED RELEASE FROM A BIODEGRADABLE ELASTOMER FOR APPLICATIONS IN CARDIOVASCULAR REGENERATIVE MEDICINE

  2008cites this paper
• Overexpression of TGFbeta1 by adeno-associated virus type-2 vector protects myocardium from ischemia-reperfusion injury.

  2008cites this paper
• Vascular endothelial growth factors in cardiovascular medicine

  2008cites this paper
• Overexpression of TGFβ1 by adeno-associated virus type-2 vector protects myocardium from ischemia–reperfusion injury

  2008cites this paper
• Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy.

  2008cites this paper
• MR assessment of myocardial perfusion, viability, and function after intramyocardial transfer of VM202, a new plasmid human hepatocyte growth factor in ischemic swine myocardium.

  2008cites this paper
• The Albuminome as a Tool for Biomarker Discovery

  2008cites this paper
• Effect of hepatocyte growth factor (HGF) on the level of Survivin & XIAP expression in several human cancer cell lines, after treating with DNA damaging agent

  2007cites this paper
• Circulating angiogenic cytokines and stem cells in patients with severe chronic ischemic heart disease--indicators of myocardial ischemic burden?

  2007cites this paper
• Mechanism of action and delivery possibilities for TGFbeta1 in the treatment of myocardial ischemia.

  2007cites this paper
• Investigation of an albumin‐enriched fraction of human serum and its albuminome

  2007cites this paper
• Effect of heparin on blood vascular endothelial growth factor levels in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention.

  2006cites this paper
• Coordinate release of angiogenic growth factors after acute myocardial infarction: evidence of a two-wave production

  2006cites this paper
• The use of transformed Escherichia coli for experimental angiogenesis induced by regulated in situ production of vascular endothelial growth factor--an alternative gene therapy.

  2005cites this paper
• Induction of Angiogenesis and Inhibition of Apoptosis by Hepatocyte Growth Factor Effectively Treats Postischemic Heart Failure

  2005cites this paper
• The therapeutic potential of hepatocyte growth factor for myocardial infarction and heart failure.

  2004cites this paper
• Improvement of oxygen metabolism in ischemic myocardium as a result of enhanced external counterpulsation with heparin pretreatment for patients with stable angina

  2004cites this paper
• Vascular endothelial growth factor - basic science and its clinical implications.

  2004cites this paper
• Gene Transfer of Hepatocyte Growth Factor Attenuates Postinfarction Heart Failure

  2003cites this paper
• Peripheral monocytes from diabetic patients with coronary artery disease display increased bFGF and VEGF mRNA expression

  2003cites this paper
• Early Treatment with Hepatocyte Growth Factor Improves Cardiac Function in Experimental Heart Failure Induced by Myocardial Infarction

  2003cites this paper
• Multiple complex coronary plaques in a patient with acute myocardial infarction

  2002cites this paper